| Promises and challenges of adoptive T-cell therapies for solid tumours M Morotti, A Albukhari, A Alsaadi, M Artibani, JD Brenton, SM Curbishley, ... British journal of cancer 124 (11), 1759-1776, 2021 | 228 | 2021 |
| Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 … T Shi, J Zhu, Y Feng, D Tu, Y Zhang, P Zhang, H Jia, X Huang, Y Cai, ... The Lancet Oncology 22 (4), 439-449, 2021 | 181 | 2021 |
| The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells Z Hu, M Artibani, A Alsaadi, N Wietek, M Morotti, T Shi, Z Zhong, ... Cancer cell 37 (2), 226-242. e7, 2020 | 162 | 2020 |
| Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population J He, MY Wang, LX Qiu, ML Zhu, TY Shi, XY Zhou, MH Sun, YJ Yang, ... Molecular carcinogenesis 52 (S1), 70-79, 2013 | 124 | 2013 |
| Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women K Chen, H Ma, L Li, R Zang, C Wang, F Song, T Shi, D Yu, M Yang, W Xue, ... Nature communications 5 (1), 4682, 2014 | 115 | 2014 |
| Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: A meta‐analysis J He, TY Shi, ML Zhu, MY Wang, QX Li, QY Wei International journal of cancer 133 (8), 1765-1775, 2013 | 99 | 2013 |
| Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes TY Shi, X Cheng, KD Yu, MH Sun, ZM Shao, MY Wang, ML Zhu, J He, ... Carcinogenesis 34 (4), 770-778, 2013 | 79 | 2013 |
| REV3L, a Promising Target in Regulating the Chemosensitivity of Cervical Cancer Cells L Yang, T Shi, F Liu, C Ren, Z Wang, Y Li, X Tu, G Yang, X Cheng PLoS One 10 (3), e0120334, 2015 | 69 | 2015 |
| BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic‐related mutations in BRCA1 associated with an increased risk of ovarian cancer T Shi, P Wang, C Xie, S Yin, D Shi, C Wei, W Tang, R Jiang, X Cheng, ... International Journal of Cancer 140 (9), 2051-2059, 2017 | 64 | 2017 |
| Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women TY Shi, ML Zhu, J He, MY Wang, QX Li, XY Zhou, MH Sun, ZM Shao, ... Human genetics 132, 301-312, 2013 | 54 | 2013 |
| A pri-miR-218variant and risk of cervical carcinoma in Chinese women TY Shi, XJ Chen, ML Zhu, MY Wang, J He, KD Yu, ZM Shao, MH Sun, ... BMC cancer 13, 1-8, 2013 | 52 | 2013 |
| Whole exome sequencing identifies frequent somatic mutations in cell-cell adhesion genes in Chinese patients with lung squamous cell carcinoma C Li, Z Gao, F Li, X Li, Y Sun, M Wang, D Li, R Wang, F Li, R Fang, Y Pan, ... Scientific reports 5 (1), 14237, 2015 | 51 | 2015 |
| A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2. R Zang, J Zhu, T Shi, J Liu, D Tu, S Yin, R Jiang, P Zhang, H Jia, Y Luan, ... Journal of Clinical Oncology 38 (15_suppl), 6001-6001, 2020 | 48 | 2020 |
| Association of LEP G2548A and LEPR Q223R Polymorphisms with Cancer Susceptibility: Evidence from a Meta-Analysis J He, B Xi, R Ruiter, TY Shi, ML Zhu, MY Wang, QX Li, XY Zhou, LX Qiu, ... PloS one 8 (10), e75135, 2013 | 46 | 2013 |
| Association between the ERCC5 Asp1104His Polymorphism and Cancer Risk: A Meta-Analysis ML Zhu, M Wang, ZG Cao, J He, TY Shi, KQ Xia, LX Qiu, QY Wei PLoS One 7 (7), e36293, 2012 | 46 | 2012 |
| The association between common genetic variant of microRNA-146a and cancer susceptibility LX Qiu, J He, MY Wang, RX Zhang, TY Shi, ML Zhu, C Mao, S Sun, FF Lv, ... Cytokine 56 (3), 695-698, 2011 | 45 | 2011 |
| Association between XPF Polymorphisms and Cancer Risk: A Meta-Analysis TY Shi, J He, LX Qiu, ML Zhu, MY Wang, XY Zhou, J Han, H Yu, RY Zang, ... PLoS One 7 (7), e38606, 2012 | 42 | 2012 |
| Polymorphisms in the mTOR Gene and Risk of Sporadic Prostate Cancer in an Eastern Chinese Population Q Li, C Gu, Y Zhu, M Wang, Y Yang, J Wang, L Jin, ML Zhu, TY Shi, J He, ... PloS one 8 (8), e71968, 2013 | 41 | 2013 |
| Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept R Jiang, J Zhu, JW Kim, J Liu, K Kato, HS Kim, Y Zhang, P Zhang, T Zhu, ... Journal of gynecologic oncology 31 (5), e86, 2020 | 38 | 2020 |
| RAD52 Variants Predict Platinum Resistance and Prognosis of Cervical Cancer TY Shi, G Yang, XY Tu, JM Yang, J Qian, XH Wu, XY Zhou, X Cheng, ... PLoS One 7 (11), e50461, 2012 | 38 | 2012 |
